The microRNA miR-34a inhibits non-small cell lung cancer (NSCLC) growth and the CD44hi stem-like NSCLC cells.

by Yang Shi, Can Liu, Xin Liu, Dean G Tang, Junchen Wang
Published 2014-01-01

MicroRNA-34a: Potent Tumor Suppressor, Cancer Stem Cell Inhibitor, and Potential Anticancer Therapeutic

by Wen (Jess) Li, Wen (Jess) Li, Yunfei Wang, Yunfei Wang, Ruifang Liu, Andrea L. Kasinski, Haifa Shen, Frank J. Slack, Dean G. Tang, Dean G. Tang
Published 2021-03-01

Deep RNA-Seq analysis reveals unexpected features of human prostate basal epithelial cells

by Dingxiao Zhang, Daechan Park, Yue Lu, Jianjun Shen, Vishwanath R. Iyer, Dean G. Tang
Published 2016-03-01

Histone 2B-GFP Label-Retaining Prostate Luminal Cells Possess Progenitor Cell Properties and Are Intrinsically Resistant to Castration

by Dingxiao Zhang, Collene Jeter, Shuai Gong, Amanda Tracz, Yue Lu, Jianjun Shen, Dean G. Tang
Published 2018-01-01

Dissociated primary human prostate cancer cells coinjected with the immortalized Hs5 bone marrow stromal cells generate undifferentiated tumors in NOD/SCID-γ mice.

by Xin Chen, Bigang Liu, Qiuhui Li, Sofia Honorio, Xin Liu, Can Liu, Asha S Multani, Tammy Calhoun-Davis, Dean G Tang
Published 2013-01-01

Defective molecular timer in the absence of nucleotides leads to inefficient caspase activation.

by Honghao Zhang, Raghu Gogada, Neelu Yadav, Ravi K Lella, Mark Badeaux, Mary Ayres, Varsha Gandhi, Dean G Tang, Dhyan Chandra
Published 2011-01-01

Maintenance Therapy Containing Metformin and/or Zyflamend for Advanced Prostate Cancer: A Case Series

by Mehmet Asim Bilen, Sue-Hwa Lin, Dean G. Tang, Kinjal Parikh, Mong-Hong Lee, Sai-Ching J. Yeung, Shi-Ming Tu
Published 2015-01-01

Reduced 15S-Lipoxygenase-2 Expression in Esophageal Cancer Specimens and Cells and Upregulation In Vitro by the Cyclooxygenase-2 Inhibitor, NS398

by Xiao-Chun Xu, Scott B. Shappell, Zhengdong Liang, Shumei Song, David Menter, Vemparala Subbarayan, Sunita Iyengar, Dean G. Tang, Scott M. Lippman
Published 2003-03-01

Activated ERM protein plays a critical role in drug resistance of MOLT4 cells induced by CCL25.

by Li Zhang, Ruijing Xiao, Jie Xiong, Jun Leng, Altaf Ehtisham, Yi Hu, Qianshan Ding, Hui Xu, Shengwu Liu, Jin Wang, Dean G Tang, Qiuping Zhang
Published 2013-01-01

Intron retention is a hallmark and spliceosome represents a therapeutic vulnerability in aggressive prostate cancer

by Dingxiao Zhang, Qiang Hu, Xiaozhuo Liu, Yibing Ji, Hsueh-Ping Chao, Yan Liu, Amanda Tracz, Jason Kirk, Silvia Buonamici, Ping Zhu, Jianmin Wang, Song Liu, Dean G. Tang
Published 2020-04-01

MicroRNA-141 suppresses prostate cancer stem cells and metastasis by targeting a cohort of pro-metastasis genes

by Can Liu, Ruifang Liu, Dingxiao Zhang, Qu Deng, Bigang Liu, Hsueh-Ping Chao, Kiera Rycaj, Yoko Takata, Kevin Lin, Yue Lu, Yi Zhong, John Krolewski, Jianjun Shen, Dean G. Tang
Published 2017-01-01

Drug-tolerant cancer cells show reduced tumor-initiating capacity: depletion of CD44 cells and evidence for epigenetic mechanisms.

by Hong Yan, Xin Chen, Qiuping Zhang, Jichao Qin, Hangwen Li, Can Liu, Tammy Calhoun-Davis, Luis Della Coletta, Jim Klostergaard, Izabela Fokt, Stanislaw Skora, Waldemar Priebe, Yongyi Bi, Dean G Tang
Published 2011-01-01

Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer

by Dingxiao Zhang, Daechan Park, Yi Zhong, Yue Lu, Kiera Rycaj, Shuai Gong, Xin Chen, Xin Liu, Hsueh-Ping Chao, Pamela Whitney, Tammy Calhoun-Davis, Yoko Takata, Jianjun Shen, Vishwanath R. Iyer, Dean G. Tang
Published 2016-02-01

Systematic evaluation of RNA-Seq preparation protocol performance

by Hsueh-Ping Chao, Yueping Chen, Yoko Takata, Mary W. Tomida, Kevin Lin, Jason S. Kirk, Melissa S. Simper, Carol D. Mikulec, Joyce E. Rundhaug, Susan M. Fischer, Taiping Chen, Dean G. Tang, Yue Lu, Jianjun Shen
Published 2019-07-01

Nanog1 in NTERA-2 and recombinant NanogP8 from somatic cancer cells adopt multiple protein conformations and migrate at multiple M.W species.

by Bigang Liu, Mark D Badeaux, Grace Choy, Dhyan Chandra, Irvin Shen, Collene R Jeter, Kiera Rycaj, Chia-Fang Lee, Maria D Person, Can Liu, Yueping Chen, Jianjun Shen, Sung Yun Jung, Jun Qin, Dean G Tang
Published 2014-01-01

LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancer

by Qiuhui Li, Bigang Liu, Hsueh-Ping Chao, Yibing Ji, Yue Lu, Rashid Mehmood, Collene Jeter, Taiping Chen, John R. Moore, Wenqian Li, Can Liu, Kiera Rycaj, Amanda Tracz, Jason Kirk, Tammy Calhoun-Davis, Jie Xiong, Qu Deng, Jiaoti Huang, Barbara A. Foster, Abhiram Gokhale, Xin Chen, Dean G. Tang
Published 2019-12-01

Author Correction: LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancer

by Qiuhui Li, Bigang Liu, Hsueh-Ping Chao, Yibing Ji, Yue Lu, Rashid Mehmood, Collene Jeter, Taiping Chen, John R. Moore, Wenqian Li, Can Liu, Kiera Rycaj, Amanda Tracz, Jason Kirk, Tammy Calhoun-Davis, Jie Xiong, Qu Deng, Jiaoti Huang, Barbara A. Foster, Abhiram Gokhale, Xin Chen, Dean G. Tang
Published 2020-06-01

Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responses

by Qiuhui Li, Qu Deng, Hsueh-Ping Chao, Xin Liu, Yue Lu, Kevin Lin, Bigang Liu, Gregory W. Tang, Dingxiao Zhang, Amanda Tracz, Collene Jeter, Kiera Rycaj, Tammy Calhoun-Davis, Jiaoti Huang, Mark A. Rubin, Himisha Beltran, Jianjun Shen, Gurkamal Chatta, Igor Puzanov, James L. Mohler, Jianmin Wang, Ruizhe Zhao, Jason Kirk, Xin Chen, Dean G. Tang
Published 2018-09-01